These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26552221)

  • 41. Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression.
    Ingthorsson S; Briem E; Bergthorsson JT; Gudjonsson T
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):139-148. PubMed ID: 27815674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy.
    Baulida J; García de Herreros A
    Biochim Biophys Acta; 2015 Aug; 1856(1):55-61. PubMed ID: 26050961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells.
    Kovacic B; Rosner M; Schipany K; Ionce L; Hengstschläger M
    Eur J Clin Invest; 2015 Apr; 45(4):415-22. PubMed ID: 25646864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermediate cell states in epithelial-to-mesenchymal transition.
    Sha Y; Haensel D; Gutierrez G; Du H; Dai X; Nie Q
    Phys Biol; 2019 Jan; 16(2):021001. PubMed ID: 30560804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
    Lee HM; Hwang KA; Choi KC
    Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical implications of epithelial cell plasticity in cancer progression.
    Aparicio LA; Blanco M; Castosa R; Concha Á; Valladares M; Calvo L; Figueroa A
    Cancer Lett; 2015 Sep; 366(1):1-10. PubMed ID: 26099173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial plasticity, cancer stem cells and bone metastasis formation.
    van der Pluijm G
    Bone; 2011 Jan; 48(1):37-43. PubMed ID: 20670698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.
    Conteduca V; Aieta M; Amadori D; De Giorgi U
    Crit Rev Oncol Hematol; 2014 Oct; 92(1):11-24. PubMed ID: 24952997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.
    Soundararajan R; Paranjape AN; Maity S; Aparicio A; Mani SA
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):229-238. PubMed ID: 29981816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer.
    Iser IC; Vedovatto S; Oliveira FD; Beckenkamp LR; Lenz G; Wink MR
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):202-213. PubMed ID: 35779713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A common framework for EMT and collective cell migration.
    Campbell K; Casanova J
    Development; 2016 Dec; 143(23):4291-4300. PubMed ID: 27899506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer.
    Jia D; Park JH; Kaur H; Jung KH; Yang S; Tripathi S; Galbraith M; Deng Y; Jolly MK; Kaipparettu BA; Onuchic JN; Levine H
    Br J Cancer; 2021 Jun; 124(12):1902-1911. PubMed ID: 33859341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression.
    Krantz SB; Shields MA; Dangi-Garimella S; Munshi HG; Bentrem DJ
    J Surg Res; 2012 Mar; 173(1):105-12. PubMed ID: 22099597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epithelial-mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation.
    Wang H; Unternaehrer JJ
    Dev Dyn; 2019 Jan; 248(1):10-20. PubMed ID: 30303578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EMT and Cancer: More Than Meets the Eye.
    Derynck R; Weinberg RA
    Dev Cell; 2019 May; 49(3):313-316. PubMed ID: 31063750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities.
    Zhang Y; Weinberg RA
    Front Med; 2018 Aug; 12(4):361-373. PubMed ID: 30043221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of proteases in epithelial-to-mesenchymal cell transitions in cancer.
    Mitschke J; Burk UC; Reinheckel T
    Cancer Metastasis Rev; 2019 Sep; 38(3):431-444. PubMed ID: 31482486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linking EMT programmes to normal and neoplastic epithelial stem cells.
    Lambert AW; Weinberg RA
    Nat Rev Cancer; 2021 May; 21(5):325-338. PubMed ID: 33547455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal-epithelial transition in development and reprogramming.
    Pei D; Shu X; Gassama-Diagne A; Thiery JP
    Nat Cell Biol; 2019 Jan; 21(1):44-53. PubMed ID: 30602762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids.
    Lee CH
    Biochem Pharmacol; 2018 Dec; 158():261-273. PubMed ID: 30389404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.